Latest Breaking News On - Shinichiro nishishita - Page 4 : vimarsana.com

Sosei Heptares to Present at 42nd Annual J P Morgan Healthcare Conference

Sosei Heptares to Present at 42nd Annual J P Morgan Healthcare Conference
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

San franciscoUnited statesSoult ukpyolsiSouth koreaUnited kingdomCity ofShinichiro nishishitaMaya bennisonChris cargillErica hollingsworthSosei heptaresKentaro taharaFrazer hallSosei group corporation forwardJw marriott hotelSosei group corporation

Sosei Group Announces Marketing Approval for PIVLAZ™ (clazosentan sodium) 150 mg in South Korea

PIVLAZ™, a new drug for prevention of Cerebral Vasospasm in patients with Aneurysmal Subarachnoid Hemorrhage (aSAH), approved in South KoreaPIVLAZ.

United kingdomCity ofSoult ukpyolsiSouth koreaKyonggi doJ clin neurosciErica hollingsworthSosei heptaresSatoshi tanakaFrazer hallMaya bennisonKentaro taharaShinichiro nishishitaSosei group corporationTokyo stock exchangeMinistry of food

Sosei Group Announces Marketing Approval for PIVLAZ™

Sosei Group Announces Marketing Approval for PIVLAZ™
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Kyonggi doSouth koreaCity ofUnited kingdomSoult ukpyolsiMaya bennisonSosei heptaresKentaro taharaJ clin neurosciSatoshi tanakaErica hollingsworthShinichiro nishishitaFrazer hallMedistrava consulting for international mediaIdorsia pharmaceuticals korea co ltdTokyo stock exchange

Sosei Heptares Partner Neurocrine Biosciences Confirms its Plans to Evaluate Two New Muscarinic Agonist Candidates in Phase 1 Clinical Studies

Sosei Heptares Partner Neurocrine Biosciences Confirms its Plans to Evaluate Two New Muscarinic Agonist Candidates in Phase 1 Clinical Studies
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomSoult ukpyolsiSouth koreaErica hollingsworthMaya bennisonNeurocrine biosciencesMatt barnesFrazer hallShinichiro nishishitaSosei heptaresKentaro taharaSosei heptareSosei group corporation the companyTokyo stock exchangeMedistrava consulting for international media

Sosei Heptares to Regain Full Ownership of GSK4381406*, a Clinic-ready, First-in-Class Oral GPR35 Agonist for Inflammatory Bowel Disease

Sosei Heptares to Regain Full Ownership of GSK4381406*, a Clinic-ready, First-in-Class Oral GPR35 Agonist for Inflammatory Bowel Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofSoult ukpyolsiSouth koreaDisclosuresmaya bennisonRelationskentaro taharaSosei heptareGsksosei heptaresShinichiro nishishitaFrazer hallSosei heptaresErica hollingsworthChris cargillCommunications managerSosei groupRegulatory agency